Zobrazeno 1 - 10
of 493
pro vyhledávání: '"Asenbaum S"'
Autor:
Borght, T. Vander1, Asenbaum, S.2, Bartenstein, P.3, Halldin, C.4, Kapucu, Ö.5, Van Laere, K.6, Varrone, A.7, Tatsch, K.8 klaus.tatsch@med.uni-muenchen.de
Publikováno v:
European Journal of Nuclear Medicine & Molecular Imaging. Nov2006, Vol. 33 Issue 11, p1374-1380. 7p.
Autor:
Lobentanz, I. S.1, Asenbaum, S.1, Vass, K.1, Sauter, C.1, Klösch, G.1, Kollegger, H.1, Kristoferitsch, W.2, Zeitihofer, J.1 josef.zeitlhofer@univie.ac.at
Publikováno v:
Acta Neurologica Scandinavica. Jul2004, Vol. 110 Issue 1, p6-13. 8p.
Autor:
Gerschlager, W., Bencsits, G., Pirker, W., Bloem, B.R., Asenbaum, S., Prayer, D., Zijlmans, J.C.M., Hoffmann, M., Brucke, T.
Publikováno v:
Movement Disorders, 17, 518-23
Movement Disorders, 17, 3, pp. 518-23
Movement Disorders, 17, 3, pp. 518-23
Item does not contain fulltext We investigated whether [(123)I]-beta-CIT and single-photon emission computed tomography (SPECT) imaging distinguishes patients with clinically suspected vascular parkinsonism (VP) from patients with idiopathic Parkinso
Autor:
Kapucu, O., Shoustari, M. Naseri, Asenbaum, S., Booij, J., Knudsen, G. M., Pagani, M., Sabri, O., Tatsch, K., Borght, T. Vander, Van Laere, K., Varrone, A., Nobili, F., Ell, P., Kemp, P., Tossici-Bolt, L.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10046::f42a988b892a9c90fce2b24d3e99dc0f
https://avesis.gazi.edu.tr/publication/details/3e70ba80-06f4-423b-83ca-407392b106ea/oai
https://avesis.gazi.edu.tr/publication/details/3e70ba80-06f4-423b-83ca-407392b106ea/oai
Autor:
Varrone, A, asenbaum, S, Vander Borght, T, Booij, J, Nobili, F, Nagren, K, Darcourt, J, Kapucu, O, Tatsch, K, Bartenstein, P, Van Laere, Koen
These guidelines summarize the current views of the European Association of Nuclear Medicine Neuroimaging Committee (ENC). The purpose of the guidelines is to assist nuclear medicine practitioners in making recommendations, performing, interpreting,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1131::f757fad59c8248a901f389a3351f9b23
https://lirias.kuleuven.be/handle/123456789/259883
https://lirias.kuleuven.be/handle/123456789/259883
Autor:
Kapucu, O., Vander Borght, T., Asenbaum, S., Halldin, C., Van Laere, K., Varrone, A., Tatsch, K., Bartenstein, P.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10046::822bc833748fe7eb951705a9e0b12dfd
https://avesis.gazi.edu.tr/publication/details/f9589680-b294-456f-94fc-19cdf6abd91b/oai
https://avesis.gazi.edu.tr/publication/details/f9589680-b294-456f-94fc-19cdf6abd91b/oai
Autor:
Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, Varrone A, Tatsch K.
Publikováno v:
European journal of nuclear medicine and molecular imaging
33 (2006): 1374–1380.
info:cnr-pdr/source/autori:Vander Borght T; Asenbaum S; Bartenstein P; Halldin C; Kapucu O; Van Laere K; Varrone A; Tatsch K./titolo:EANM procedure guidelines for brain tumor imaging using labelled amino acid analogues./doi:/rivista:European journal of nuclear medicine and molecular imaging (Print)/anno:2006/pagina_da:1374/pagina_a:1380/intervallo_pagine:1374–1380/volume:33
33 (2006): 1374–1380.
info:cnr-pdr/source/autori:Vander Borght T; Asenbaum S; Bartenstein P; Halldin C; Kapucu O; Van Laere K; Varrone A; Tatsch K./titolo:EANM procedure guidelines for brain tumor imaging using labelled amino acid analogues./doi:/rivista:European journal of nuclear medicine and molecular imaging (Print)/anno:2006/pagina_da:1374/pagina_a:1380/intervallo_pagine:1374–1380/volume:33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::8b34399fd86244420b4c7a4e643b95df
https://publications.cnr.it/doc/13683
https://publications.cnr.it/doc/13683
Autor:
Catafau, A. M, Tolosa, E, Antonini, A, Benti, R, Sorbi, S, Pupi, A, Cunha, L, de Lima, J. P., Vallderiola, F, Lomeña, F, Kulisevsky, J, Weeks, R, Buxton-Thomas, M, Gibb, W. R. G, Kemp, P. M, Asenbaum, S, Dudczak, R.
Imaging with (123)I-Ioflupane single-photon emission computed tomography (SPECT) is a marker of nigrostriatal neuronal integrity, allowing differentiation of parkinsonism with loss of dopaminergic terminals (presynaptic Parkinson syndrome [PS]) from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::139e9c4e32e1aee8f95e39630121fc1b
http://hdl.handle.net/11577/3252257
http://hdl.handle.net/11577/3252257
Autor:
Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Christian Wöber, Müller C, Deecke L
Publikováno v:
Europe PubMed Central
The aim of the present study was to demonstrate the degeneration of the dopaminergic nigrostriatal pathway in Parkinson's disease by using the cocaine derivative [123I]beta-CIT (2-beta-carbomethoxy-3-beta(4-iodophenyl)-tropane or RTI-55) and SPECT an
Autor:
Pirker, W., Riedl, M., Luger, A., Czech, T., Rossler, K., Asenbaum, S., Angelberger, P., Johannes Kornhuber, Deecke, L., Podreka, I., Brucke, T.
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Epidepride is a novel benzamide derivative with high affinity for D2 receptors. Epidepride, in its 123I-labeled form, can be used for SPECT imaging of striatal and extrastriatal dopamine D2 receptors. The present study evaluated the usefulness of epi